Zysis. Reformulation – Pharmaceutical – Biotechnology
Never miss Zysis.com updates: Start reading the news feed of Zysis right away! This site’s feed is stale or rarely updated (or it might be broken for a reason), but you may check related news or Zysis.com popular pages instead. It is generally safe for browsing, so you may click any item to proceed to the site.
News, stories and media buzz related to Zysis
-
FDA Approves ARISTADA™ for Treatment of Schizophreniavia
military-technologies
This post was originally published on this site DUBLIN–(satPRnews.com)–Alkermes plc (NASDAQ: ALKS) today announced that the U.S. Food and Drug Administration (FDA) has approved ARISTADA™ (aripiprazole lauroxil) extended-release injectable suspension...
-
FDA Approves Alkermes’ Schizophrenia Drugvia
spjnews
DUBLIN–(BUSINESS WIRE)–Oct. 5, 2015– Alkermes plc (NASDAQ: ALKS) today announced that the U.S. Food and Drug Administration (FDA) has approved ARISTADA™ (aripiprazole lauroxil) extended-release injectable suspension for the treatment of schizophrenia...
-
Otsuka and Lundbeck’s Once-Monthly Abilify Maintena(R) (Aripiprazole) Now Approved in Europevia
newdrugapprovals.wordpress
Otsuka and Lundbeck’s Once-Monthly Abilify Maintena(R) (Aripiprazole) Now Approved in Europe for Maintenance Treatment of Schizophrenia in Adult Patients Stabilized with Oral Aripiprazole do not forget to see my old blog post, contains synthesis...
-
Pharmaceutical Innovation in the Treatment of Schizophrenia and Mental Disorders Compared with Other Diseasesvia
innovationscns
by Joanna P. MacEwan, PhD; Seth Seabury, PhD; Myrlene Sanon Aigbogun, MPH; Siddhesh Kamat, MS, MBA; Emma van Eijndhoven, MS, MA; Clement Francois, PhD; Crystal Henderson, PharmD, BCPP; and Leslie Citrome, MD, MPH Dr. MacEwan and Ms. van Eijndhoven are...
-
Aequus Announces Positive Results From Single-Dose Bioavailability Study of Aripiprazole Transdermal Patchvia
tribune
VANCOUVER, BRITISH COLUMBIA—(Marketwired – Feb 4, 2016) – Aequus Pharmaceuticals Inc. (TSX VENTURE:AQS)(OTCQB:AQSZF) (“Aequus” or the “Company”), announced today positive results from an initial bioavailability study of its lead development program,...
Zysis.com popular pages
-
Zysis – Drug Reformulation – Pharmaceutical – Biotechnology
Reformulation – Pharmaceutical – Biotechnology
-
Zysis – Drug Reformulation – Pharmaceutical – Biotechnology » Treatment and Non-Adherence
Rev Psiquiatr Salud Ment. 2014 Apr-Jun;7(2):64-71 Authors: González-Rodríguez A, Molina-Andreu O, Imaz Gurrutxaga ML, Catalán Campos R, Arroyo MB Abstract INTRODUCTION: Gender differences in...
-
Zysis – Drug Reformulation – Pharmaceutical – Biotechnology » Treatment and Non-Adherence
Bipolar Disord. 2015 Mar 2; Authors: Pallaskorpi S, Suominen K, Ketokivi M, Mantere O, Arvilommi P, Valtonen H, Leppämäki S, Isometsä E Abstract OBJECTIVES: The long-term outcome of bipolar ...
Some worthy website to observe next
Website parameters
-
19 years
Domain age
-
N/A
Visit duration
-
N/A
Daily visitors
-
N/A
Bounce rate
